Our data both identify iron uptake into the brain, and FPN1 in particular, as a target for the treatment of ischemic stroke at the acute phase, while demonstrating that long-term limitation of brain iron import will impair stroke recovery. This evidence concerns the gene SLC40A1 and ischemic stroke.